Zhejiang Wolwo Bio-Pharmaceutical's actual controller changes due to divorce; Hu Gengxi resigns as chairman

Management
โดย 上海证券报·CN·Read original
Summary · why it matters

Zhejiang Wolwo Bio-Pharmaceutical announced that, due to the dissolution of the marriage between actual controller Hu Gengxi and Yanni Chen and the subsequent division of property, the company's actual controller will change from Hu Gengxi and Yanni Chen to Yanni Chen, while the controlling shareholder remains Zhejiang Wolwo Management Consulting. Shares directly held by Hu Gengxi remain his personal property, his 100% equity in Mingchen Investment goes to his grandson Niu Chen'an, and the 100% equity in Hong Kong Haorui held by Yanni Chen remains her personal property. Mingchen Investment and Hong Kong Haorui hold 33.87% and 40% of Wolwo Consulting respectively, and Wolwo Consulting holds 38.86% of Zhejiang Wolwo Bio-Pharmaceutical. On the same day, Hu Gengxi resigned from all positions including chairman for personal reasons and no longer serves as legal representative. Before a new chairman is elected, Yanni Chen will perform the duties of chairman. In the first half of 2026, Zhejiang Wolwo Bio-Pharmaceutical achieved operating revenue of 514 million yuan, up 6.18% year on year, and net profit of 213 million yuan, up 20.59% year on year.

Impact on stocks 1

Others▲ · 1 stocks

Off-coverage companies 2

浙江我武管理咨询有限公司Private± Mixed
Regulationrelevance

Wolwo Consulting remains controlling shareholder holding 38.86% of the listed company amid the controller change.

铭晨投资Private± Mixed
Regulationrelevance

Mingchen Investment's 100% equity transfers to grandson Niu Chen'an as part of the divorce property division.

© 2026 MarketDXNews